Alzheimer's Disease: The Brand
  • Why Alzheimer's Disease?
  • Curating and Creating
  • Alzheimer's Disease: The Brand...the book!
Keep tabs on the journey...
UA-62070106-1

Decisions for next generation therapeutics

7/11/2015

 
Decision analysis in medicine has not been broadly applied to clinical decision making. It seems particularly suited for high-value decision making where it is imperative to assess uncertainty and complexity with a common goal to optimize decision outcome variables. Balancing Costs and Benefits at Different Stages of Medical Innovation: a Systematic Review of Multi-Criteria Decision Analysis (MCDA) exemplifies the process in a clinical setting, an extension from its origins in engineering and technical frameworks. Decision analysis seeks to address ambiguity and convey recommendations, gain consensus, develop and execute single recommendations or simplify disparate understandings of complex disease states..
Executives are often asked to make critical choices based on gut feel. Even an experienced engineer would not attempt to build a sound bridge this way, and the executive, even one with a great education and lots of experience, should not be expected to arrive a sound decisions this way either. Like a sound bridge design, a good decision needs to be properly engineered; it is naive to guess the answers directly.
Click on the interactive map to see how dragging the Decision Intelligence bubble moves the network and focuses the inputs.
The Decision Intelligence and Decision Engineering Ecosystem interactive map
Picture
I use these advances in decision intelligence and analysis of data systems to explore complex clinical syndromes and diseases. Building an ecosystem that is responsive and reflexive requires collaborative mapping and differentiation of complex networks. These are certainly team-based discussions and models that are not trivial in diffuse clinical conditions like Alzheimer's disease.
Thus, the optimal prevention and treatment of AD and MCI (mild cognitive impairment) may ultimately be informed by the precedents set during development of successful therapeutics for other chronic illnesses such as cardiovascular disease, osteoporosis and cancer. Although the development and optimization of systems of therapeutics would require radical modernization and streamlining of the current complex structure involved with drug development, approval and administration, the increasing gravity of the failure to develop effective therapeutics for Alzheimer’s disease argues that such therapeutic systems should be considered thoughtfully.--Bredesen 2013

An inability to charactize the etiology of Alzheimer's disease hints at the need for an evolving mechanism that explains the multiple mechanisms involved in pathogenesis. Modernization of current perspectives that include prevention and consideration of age-associated chronic diseases should help narrow the funnel and create targeted algorithms that include lifestyle and social determinants of health outcomes.
Put these developments together with tools like the New York Times’ “You Draw it!” visual relationship drawing widget and all the players in the emerging Decision Intelligence ecosystem, and we can see how the pieces fit together to form a new machine.   It’s not just automated systems, but humans in the loop solving problems that go beyond sales and marketing.  

Comments are closed.
    Picture

    Bonny

    A data analyst focuses the lens on the evolution of Alzheimer's Disease as a diagnosis into a billion dollar healthcare juggernaut

    Sign up for newsletter:

    Categories

    All
    Alzheimer's Disease
    Blog
    Medical Writer
    WHCOA

    ADTB remains a labor of love. It honors my dad and his journey with Alzheimer's disease.

    ​I spend quite a bit of time traveling and researching and hope to publish an expanded discussion of many of these insights.

    If you are able to and indeed benefit from my efforts I would appreciate your donation to keep the site ad-free and relevant.

    How about enough for a coffee? Any amount is appreciated. Thank you!
    Follow our blog about the intersection of health policy, economics, and clinical medicine.
    Picture
Powered by Create your own unique website with customizable templates.